Syntellix AG - Internationally Renowned Scientist: "Magnesium is the New Gold Standard"

Hannover (ots) -

- Internationally renowned expert describes Magnesium as "New Gold
Standard" for orthopaedic and trauma surgery
- Trendsetting presentation at major congress in Surakarta/Java
- By today, Syntellix is the only medtech company in the world
that can offer and supply Magnesium based bioabsorbable implants
for the use in orthopaedic and trauma surgery with CE Approval
and successful product registrations in many other countries
including high-tech regimes such as Australia, Israel and
Singapore as well as high-population/growth countries such as
Mexico, Indonesia and Vietnam
- Professor Gowreeson Thevendran, Raffles Hospital/Singapore: "In
5 years that I work with these implants, I have not seen any
adverse effects in patients. They are as good as titanium, but
have many advantages."

At the occasion of the 67th CONTINUING ORTHOPAEDIC EDUCATION (COE)
CONGRESS OF THE INDONESIAN ORTHOPAEDIC ASSOCIATION that took place
from 24 April 2019 to 27 April 2019 at Solo City (Surakarta) / Java,
internationally renowned scientist and orthopaedic surgeon Professor
Gowreeson Thevendran from Singapore, based on his excellent
experience over several years with Syntellix' MAGNEZIX bioabsorbable
implants, has described Magnesium as the "New Gold Standard" for
orthopaedic and trauma surgery. In his widely recognized trendsetting
presentation in front of more than 100 experts from the entire
region, Professor Thevendran highlighted that in his clear
experience, these highly innovative Magnesium based implants have no
disadvantages, but many advantages compared with conventional
implants made from Titanium. These numerous advantages by far exceed
the key differentiator of bioabsorbability, which renders obsolete a
second surgery for implant removal in case of use of Magnesium based
implants, thus eliminating the corresponding infection, anaesthesia,
and refracture risks.

Professor Thevendran, who has succesfully used Syntellix' MAGNEZIX
implants over several years in various leading Singaporean hospitals
(Tan Tock Seng, Mount Elizabeth Novena, and Raffles Hospital),
explained to the expert audience: "In 5 years that I work with these
implants, I have not seen any adverse effects in patients. They are
as good as titanium, but have many advantages." In the following
discussion with congress participants, Professor Thevendran
concluded: "I genuinely believe that Magnesium will be the Gold
Standard."

About Syntellix:

Syntellix is an internationally operating medical technology
company with headquarters in Hannover, Germany, that is undergoing
dynamic organic growth. The company specialises in the research and
development and marketing and sales of highly innovative
transformable metallic implants. Products made from the company's
patented MAGNEZIX® are unique. In a widely acclaimed publication,
they were evaluated as being superior clinically to titanium implants
commonly used. MAGNEZIX® implants degrade and are bioabsorbed in the
body and are transformed into the body's own bone tissue, and in
doing so offer an ideal combination of stability, elasticity and
bioabsorbability.

Syntellix is the world's market and technology leader in the field
of bioabsorbable metallic orthopaedic implants and has already been
honoured with numerous important awards and prizes. In Germany, these
include the Innovation Award of the German Economy 2012/13, the
Future Award 2016 of the German Healthcare Economy, the German
Medical Award 2017, the STEP Award 2017 and the Innovator of the Year
2017 award; internationally, the implants were a winner in the
Product of the Year category of the Sustainability Award 2018
program.

Contact at Syntellix AG:
Pierre Frega
Tel. (+49) 511 270413-61
presse@syntellix.com
www.syntellix.com

Syntellix AG
Aegidientorplatz 2a
30159 Hannover
Germany

Original-Content von: Syntellix AG, übermittelt durch news aktuell